Literature DB >> 10846849

A cure for cancer? Dealing with minimal residual disease.

G C O'Sullivan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10846849     DOI： 10.1007/bf03170474

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  31 in total

1.  Conditional mutator phenotypes in hMSH2-deficient tumor cell lines.

Authors:  B Richards; H Zhang; G Phear; M Meuth
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

2.  Regional immunosuppression in esophageal squamous cancer: evidence from functional studies with matched lymph nodes.

Authors:  G C O'Sullivan; A R Corbett; F Shanahan; J K Collins
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

Review 3.  Cancer vaccines.

Authors:  D M Pardoll
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

4.  Micrometastases: marker of metastatic potential or evidence of residual disease?

Authors:  G C O'Sullivan; J K Collins; J Kelly; J Morgan; M Madden; F Shanahan
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

Review 5.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

Review 6.  Therapy of lymphoma directed at idiotypes.

Authors:  R Levy; R A Miller
Journal:  J Natl Cancer Inst Monogr       Date:  1990

7.  Micrometastases in esophagogastric cancer: high detection rate in resected rib segments.

Authors:  G C O'sullivan; D Sheehan; A Clarke; R Stuart; J Kelly; M D Kiely; T Walsh; J K Collins; F Shanahan
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

8.  Angiostatin induces and sustains dormancy of human primary tumors in mice.

Authors:  M S O'Reilly; L Holmgren; C Chen; J Folkman
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

9.  Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases.

Authors:  K Pantel; J Izbicki; B Passlick; M Angstwurm; K Häussinger; O Thetter; G Riethmüller
Journal:  Lancet       Date:  1996-03-09       Impact factor: 79.321

10.  Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.

Authors:  L Holmgren; M S O'Reilly; J Folkman
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.